Thrombophilia is a topic that frequently appears in discussions about pregnancy losses, biochemical pregnancies, difficult implantation or repeatedly unfavorable reproductive outcomes. However, the connection between thrombophilia and infertility must be analyzed with caution. Not every difficulty in achieving pregnancy is explained by this diagnosis, and extensive testing performed without a clear indication may lead to confusion, anxiety and treatments that are not always necessary.
In reproductive evaluation, the doctor looks at the entire context: age, pregnancy history, results of previous procedures, quality of ovulation, uterine status, male factor and the results of basic investigations. For this reason, before thrombophilia is considered, it is important for the diagnostic pathway to be built logically, including relevant tests for fertility and hormonal function, when these are indicated.
What Thrombophilia Means and Why It Should Not Be Interpreted in Isolation
Thrombophilia describes an increased predisposition of the body to form blood clots. This predisposition may be inherited or acquired. In practice, the two situations do not have the same significance and are not automatically managed in the same way.
Some hereditary forms of thrombophilia are associated especially with the risk of venous thrombosis, particularly in contexts such as pregnancy, the postpartum period, surgical interventions, prolonged immobilization or the use of certain hormonal treatments. On the other hand, antiphospholipid syndrome, an acquired form of thrombophilia, is more clearly associated with certain obstetric complications and recurrent pregnancy loss.
For this reason, when thrombophilia and infertility are discussed, it is essential not to place an equal sign between “a positive test result” and “the cause of infertility”. A laboratory result has value only if it is interpreted in the context of your medical and reproductive history.
When Thrombophilia May Be Discussed in Reproductive Evaluation
Thrombophilia is not usually the first explanation searched for when pregnancy is delayed. In many cases, the initial investigations focus on ovulation, ovarian reserve, semen analysis, the uterine cavity, fallopian tubes, endometrium and hormonal or metabolic factors. However, there are situations in which thrombophilia and infertility become a relevant topic during consultation.
Repeated Pregnancy Losses and Biochemical Pregnancies
One of the situations in which the doctor may consider additional evaluation is a history of recurrent pregnancy losses. This is especially relevant if the losses were clinically documented or if repeated episodes raise suspicion of a systemic, uterine, genetic, immunological or hematological issue.
Repeated biochemical pregnancies may be more difficult to interpret, because they do not all have the same medical significance. Sometimes, they may reflect random embryonic abnormalities, age-related factors, endometrial particularities or other causes. In such cases, the discussion about thrombophilia and infertility must be integrated into a broader evaluation, not treated as a single answer.
If pregnancy is achieved, but there are risk factors or a particular obstetric history, monitoring must be individualized. At this stage, the investigations recommended during pregnancy for monitoring maternal-fetal evolution may also become relevant, established according to gestational age and the medical profile.
Suggestive Personal or Family History
Thrombophilia may also be discussed when there is a personal history of venous thrombosis, pulmonary embolism, thrombosis occurring at a young age or repeated episodes of blood clots. Family history also matters, especially if close relatives have had significant thrombotic events.
Another important context is the presence of autoimmune diseases or previous results that raise suspicion of antiphospholipid syndrome. In these situations, evaluation should not be reduced to a standard set of tests. The doctor may recommend a coordinated approach, sometimes together with a hematologist or a maternal-fetal medicine specialist.
What Tests May Be Discussed and Why “Package” Testing Is Not Recommended
Different tests may be discussed in evaluation, depending on the clinical suspicion. Some target hereditary thrombophilias, while others assess antiphospholipid syndrome. However, extensive testing without clear criteria is not routinely recommended in infertility.
The reason is simple: a positive result does not always mean that the factor explains infertility, pregnancy loss or a negative IVF result. In addition, certain results may be influenced by pregnancy, treatments, inflammation, anticoagulants or the timing of blood collection. For this reason, interpretation must be done carefully, and some tests must be repeated at medically established intervals in order to confirm their relevance.
In practice, the doctor may consider testing when there is:
- recurrent pregnancy loss or late pregnancy loss;
- personal history of thrombosis;
- strongly suggestive family history;
- suspicion of antiphospholipid syndrome;
- previous obstetric complications that justify additional evaluation.
In the absence of these elements, the connection between thrombophilia and infertility should be approached with restraint. The goal is not to perform as many tests as possible, but to identify those investigations that can concretely change the medical plan.
Thrombophilia, IVF and Monitoring After Pregnancy Is Achieved
In the context of In Vitro Fertilization, thrombophilia may be discussed especially if there are repeated pregnancy losses, recurrent biochemical pregnancies, implantation failures or a medical history that justifies additional investigations. However, thrombophilia does not automatically explain an unsuccessful IVF cycle.
After a negative result, the evaluation must remain balanced. The doctor may analyze embryo quality, ovarian response, the endometrium, timing of transfer, male factor, uterine history and possible less obvious causes. In this context, a structured discussion about possible medical steps after IVF that did not lead to pregnancy is useful before attributing the result to a single cause.
If thrombophilia is confirmed and considered relevant, management may include closer monitoring, interdisciplinary collaboration or anticoagulant treatment in carefully selected situations. These decisions should not be taken preventively, without indication, because any treatment has benefits, limits and risks.
“You deserve to be listened to, seen, treated with respect and supported throughout every stage of life.”
Andreas Vythoulkas
Specialist in Obstetrics and Gynecology
Frequently Asked Questions
Can thrombophilia cause infertility?
Thrombophilia is not usually considered a direct cause of infertility in the classic sense of the term. It may become relevant in certain reproductive contexts, especially when there are recurrent pregnancy losses, suspicion of antiphospholipid syndrome or a suggestive medical history.
When is thrombophilia testing recommended in infertility?
Testing may be discussed if you have repeated pregnancy losses, personal thrombotic events, important family history or previous obstetric complications. In the absence of these elements, routine testing is not always useful.
Can repeated biochemical pregnancies be linked to thrombophilia?
Sometimes, thrombophilia may be part of the discussion, but repeated biochemical pregnancies can have many explanations. The doctor will also analyze age, embryo quality, the endometrium, IVF history, genetic factors and other elements before recommending specific investigations.
If I have thrombophilia, do I automatically need anticoagulant treatment?
No. Treatment depends on the type of thrombophilia, personal history, thrombosis risk, obstetric history and reproductive timing. The decision must be made individually by the doctor, sometimes with the involvement of a hematologist.
Does thrombophilia explain a negative IVF result?
Not necessarily. A negative IVF result can have multiple causes, from embryonic and endometrial factors to elements related to protocol, age or the biology of each case. Thrombophilia is analyzed only if there are clear medical reasons.
Is a single positive result enough for diagnosis?
It depends on the test. Some results must be confirmed, and for antiphospholipid syndrome, specific clinical and laboratory criteria are required. For this reason, isolated interpretation of a test can be misleading.
Why Choose Genesis Athens for Thrombophilia Evaluation in a Reproductive Context
At Genesis Athens, the evaluation of infertility cases is built on a step-by-step approach, in which investigations are recommended according to medical history, previous results and the reproductive objective. Thrombophilia is not treated as a universal explanation, but as a possible element within a broader clinical picture.
This approach is especially important in cases involving pregnancy losses, repeated biochemical pregnancies or previous unsuccessful IVF treatments. In such situations, the medical team aims to differentiate between embryonic, uterine, hormonal, immunological, hematological and male causes, so that the next plan is justified, not built on assumptions.
Genesis Athens offers a medical setting in which thrombophilia and infertility can be discussed responsibly, with recommendations adapted to each case and with attention to the balance between useful investigations, necessary treatments and avoiding interventions without a clear indication.
Talk to a specialist about
thrombophilia and infertility
Sources:
Thrombophilia and Infertility: When It May Become Relevant in Reproductive Evaluation
Specialist in Obstetrics and Gynecology
Similar Articles
Egg Donation | What It Is, How It Works & When It’s Advised
Specialist in Obstetrics and Gynecology
Sperm Bank: What It Means, How It Works and What Questions to Ask
Specialist in Obstetrics and Gynecology
Period Symptoms in the First Month of Pregnancy: What Is Normal and When Evaluation Is Needed
Specialist in Obstetrics and Gynecology